D'Orazio & Associates, Inc. Vanda Pharmaceuticals Inc. Transaction History

D'Orazio & Associates, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 04, 2018	SELL	$14.05 - $20.2 $21,075 - $30,300	-1,500 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$12.85 - $18.1 $12,850 - $18,100	1,000 Added 200.0%	1,500 $23,000
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $7,700 - $9,425	500	500 $9,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $249M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of D'Orazio & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on D'Orazio & Associates, Inc. with notifications on news.